Enterprise Bank & Trust’s GSK GSK Stock Holding History

Enterprise Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$939K	Sell	24,455 -161	-0.7%	-$6.15K	0.35%	58
2025 Q1	$954K	Sell	24,616 -2,276	-8%	-$83.3K	0.37%	57
2024 Q4	$909K	Buy	26,892 +791	+3%	+$28.5K	0.3%	61
2024 Q3	$1.07M	Buy	26,101 +493	+2%	+$20.2K	0.34%	55
2024 Q2	$986K	Buy	25,608 +824	+3%	+$34.7K	0.34%	58
2024 Q1	$1.06M	Sell	24,784 -473	-2%	-$19.5K	0.36%	55
2023 Q4	$936K	Buy	25,257 +3,219	+15%	+$116K	0.33%	58
2023 Q3	$799K	Buy	22,038 +255	+1%	+$9.05K	0.33%	59
2023 Q2	$776K	Buy	21,783 +301	+1%	+$10.8K	0.3%	64
2023 Q1	$764K	Buy	21,482 +629	+3%	+$22K	0.33%	62
2022 Q4	$733K	Buy	+20,853	New	+$695K	0.35%	63

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Enterprise Bank & Trust's GSK Position: Q2 2025 in Review

Enterprise Bank & Trust reduced its GSK (GSK) stake by 0.65% in Q2 2025, selling an estimated $6.15K and leaving 24,455 shares worth $939K. The position accounts for 0.35% of the portfolio, ranked #58.

Enterprise Bank & Trust first reported a position in GSK in Q4 2022 and has held it in 11 quarters since. The position peaked at $1.07M in Q3 2024. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Enterprise Bank & Trust held 24,455 shares of GSK worth $939K as of Q2 2025.
Enterprise Bank & Trust sold 161 GSK shares in Q2 2025, an estimated $6.15K.
GSK made up 0.35% of Enterprise Bank & Trust's portfolio in Q2 2025, its #58 holding.
Enterprise Bank & Trust first reported a position in GSK in Q4 2022 and has held it in 11 quarters since.
Enterprise Bank & Trust's GSK position peaked at $1.07M in Q3 2024.
891 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Enterprise Bank & Trust's 13F filing for Q2 2025, filed 7 Jul 2025.